Companies / Madrigal Pharmaceuticals, Inc. / Activity
Activity — Madrigal Pharmaceuticals, Inc.
97 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $1.28M | -2K -1.24% | 194,222 0.84% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $1.27M | -2K -1.20% | 202,553 0.88% of shares | medium |
| Jan 20, 2026 | Taub Rebecca Director | Sell | Common Stock | $1.10M | -2K -0.49% | 453,351 1.96% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $1.06M | -2K -0.44% | 466,999 2.02% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $1.03M | -2K -0.96% | 205,769 0.89% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $822.1K | -2K -0.81% | 191,596 0.83% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $814.0K | -2K -0.33% | 469,564 2.03% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $781.9K | -1K -0.32% | 460,906 1.99% of shares | medium |
| Jan 26, 2026 | Sibold William John CEO | Sell | Common Stock | $776.5K | -2K -1.05% | 148,497 0.64% of shares | medium |
| May 22, 2026 | Levy Richard S Director | Sell | Common Stock | $774.8K | -1K -6.14% | 22,877 0.10% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $757.7K | -1K -0.70% | 210,204 0.91% of shares | medium |
| Mar 6, 2026 | Sibold William John CEO | Sell | Common Stock | $718.3K | -2K -1.02% | 161,829 0.70% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $707.0K | -1K -0.67% | 201,190 0.87% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $699.6K | -1K -0.29% | 462,395 2.00% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $692.2K | -1K -0.64% | 207,765 0.90% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $628.4K | -1K -0.61% | 196,654 0.85% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $598.1K | -1K -0.25% | 458,858 1.99% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $561.3K | -1K -0.52% | 209,110 0.91% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $560.7K | -1K -0.55% | 193,156 0.84% of shares | medium |
| Jun 1, 2026 | Soergel David Executive | Sell | Common Stock | $516.6K | -1K -9.41% | 10,033 0.04% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $507.3K | -970 -0.49% | 197,853 0.86% of shares | medium |
| Mar 2, 2026 | Dier Mardi Executive | Sell | Common Stock | $505.4K | -1K -11.33% | 9,257 0.04% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $503.1K | -970 -0.21% | 466,029 2.02% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $492.6K | -960 -0.20% | 472,079 2.04% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $491.5K | -960 -0.20% | 473,039 2.05% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $482.2K | -937 -0.20% | 471,142 2.04% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $480.3K | -913 -0.20% | 459,993 1.99% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $439.8K | -846 -0.42% | 200,344 0.87% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $438.5K | -840 -0.42% | 198,823 0.86% of shares | medium |
| May 18, 2026 | Soergel David Executive | Sell | Common Stock | $435.4K | -844 -7.08% | 11,075 0.05% of shares | medium |
| May 22, 2026 | Levy Richard S Director | Sell | Common Stock | $405.7K | -782 -3.42% | 22,095 0.10% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $395.9K | -766 -0.37% | 205,003 0.89% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $382.8K | -732 -0.16% | 463,730 2.01% of shares | medium |
| May 22, 2026 | Levy Richard S Director | Sell | Common Stock | $373.7K | -723 -2.88% | 24,374 0.11% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $365.7K | -691 -0.36% | 190,330 0.82% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $354.8K | -681 -0.34% | 199,663 0.86% of shares | medium |
| May 22, 2026 | Levy Richard S Director | Sell | Common Stock | $339.0K | -657 -2.55% | 25,097 0.11% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $324.2K | -600 -0.32% | 187,204 0.81% of shares | medium |
| Jan 26, 2026 | Taub Rebecca Director | Sell | Common Stock | $318.6K | -647 -0.14% | 452,704 1.96% of shares | medium |
| May 22, 2026 | Levy Richard S Director | Sell | Common Stock | $312.0K | -610 -2.24% | 26,576 0.12% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $306.9K | -588 -0.13% | 464,462 2.01% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $303.7K | -575 -0.30% | 191,021 0.83% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $293.2K | -554 -0.12% | 457,839 1.98% of shares | medium |
| Jan 26, 2026 | Huntsman Carole Executive | Sell | Common Stock | $281.9K | -570 -5.88% | 9,122 0.04% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $280.2K | -539 -0.12% | 465,490 2.01% of shares | medium |
| Mar 6, 2026 | Dier Mardi Executive | Sell | Common Stock | $279.0K | -646 -4.46% | 13,826 0.06% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $269.3K | -521 -0.11% | 469,043 2.03% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $261.5K | -487 -0.26% | 188,364 0.82% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $258.8K | -480 -0.25% | 187,804 0.81% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $253.5K | -473 -0.25% | 188,851 0.82% of shares | medium |